B

Biodyne Co Ltd
KOSDAQ:314930

Watchlist Manager
Biodyne Co Ltd
KOSDAQ:314930
Watchlist
Price: 20 650 KRW 1.98%
Market Cap: 608.7B KRW
Have any thoughts about
Biodyne Co Ltd?
Write Note

Intrinsic Value

Biodyne Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Biodyne Co Ltd stock under the Base Case scenario is 480.58 KRW. Compared to the current market price of 20 650 KRW, Biodyne Co Ltd is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
480.58 KRW
Overvaluation 98%
Intrinsic Value
Price
B
Base Case Scenario

Valuation Backtest
Biodyne Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Biodyne Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Biodyne Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Biodyne Co Ltd

Provide an overview of the primary business activities
of Biodyne Co Ltd.

What unique competitive advantages
does Biodyne Co Ltd hold over its rivals?

What risks and challenges
does Biodyne Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biodyne Co Ltd.

Provide P/S
for Biodyne Co Ltd.

Provide P/E
for Biodyne Co Ltd.

Provide P/OCF
for Biodyne Co Ltd.

Provide P/FCFE
for Biodyne Co Ltd.

Provide P/B
for Biodyne Co Ltd.

Provide EV/S
for Biodyne Co Ltd.

Provide EV/GP
for Biodyne Co Ltd.

Provide EV/EBITDA
for Biodyne Co Ltd.

Provide EV/EBIT
for Biodyne Co Ltd.

Provide EV/OCF
for Biodyne Co Ltd.

Provide EV/FCFF
for Biodyne Co Ltd.

Provide EV/IC
for Biodyne Co Ltd.

Compare the intrinsic valuations
of Biodyne Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biodyne Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biodyne Co Ltd compared to its peers.

Compare the P/E ratios
of Biodyne Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Biodyne Co Ltd with its peers.

Analyze the financial leverage
of Biodyne Co Ltd compared to its main competitors.

Show all profitability ratios
for Biodyne Co Ltd.

Provide ROE
for Biodyne Co Ltd.

Provide ROA
for Biodyne Co Ltd.

Provide ROIC
for Biodyne Co Ltd.

Provide ROCE
for Biodyne Co Ltd.

Provide Gross Margin
for Biodyne Co Ltd.

Provide Operating Margin
for Biodyne Co Ltd.

Provide Net Margin
for Biodyne Co Ltd.

Provide FCF Margin
for Biodyne Co Ltd.

Show all solvency ratios
for Biodyne Co Ltd.

Provide D/E Ratio
for Biodyne Co Ltd.

Provide D/A Ratio
for Biodyne Co Ltd.

Provide Interest Coverage Ratio
for Biodyne Co Ltd.

Provide Altman Z-Score Ratio
for Biodyne Co Ltd.

Provide Quick Ratio
for Biodyne Co Ltd.

Provide Current Ratio
for Biodyne Co Ltd.

Provide Cash Ratio
for Biodyne Co Ltd.

What is the historical Revenue growth
over the last 5 years for Biodyne Co Ltd?

What is the historical Net Income growth
over the last 5 years for Biodyne Co Ltd?

What is the current Free Cash Flow
of Biodyne Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biodyne Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biodyne Co Ltd

Current Assets 22B
Cash & Short-Term Investments 20.1B
Receivables 1.4B
Other Current Assets 610.6m
Non-Current Assets 22.3B
Long-Term Investments 7.2B
PP&E 11.1B
Intangibles 3.7B
Other Non-Current Assets 312.2m
Current Liabilities 1.2B
Accounts Payable 144.7m
Accrued Liabilities 145.7m
Other Current Liabilities 939m
Efficiency

Earnings Waterfall
Biodyne Co Ltd

Revenue
4.2B KRW
Cost of Revenue
-3.3B KRW
Gross Profit
921.1m KRW
Operating Expenses
-3B KRW
Operating Income
-2.1B KRW
Other Expenses
1.2B KRW
Net Income
-892.8m KRW

Free Cash Flow Analysis
Biodyne Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Biodyne Co Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Negative 3-Years Revenue Growth
34/100
Profitability
Score

Biodyne Co Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Biodyne Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

Biodyne Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Biodyne Co Ltd

There are no price targets for Biodyne Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Biodyne Co Ltd?

Click here to dive deeper.

Dividends

Biodyne Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Biodyne Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Biodyne Co Ltd

Country

Korea

Industry

Health Care

Market Cap

608.7B KRW

Dividend Yield

0%

Description

Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.

Contact

SEOUL
Seoul
24-4, Achasan-ro 5-gil, Seongdong-gu
+8215224811
www.biodyne.asia

IPO

2021-03-17

Employees

26

Officers

See Also

Discover More
What is the Intrinsic Value of one Biodyne Co Ltd stock?

The intrinsic value of one Biodyne Co Ltd stock under the Base Case scenario is 480.58 KRW.

Is Biodyne Co Ltd stock undervalued or overvalued?

Compared to the current market price of 20 650 KRW, Biodyne Co Ltd is Overvalued by 98%.

Back to Top